International journal of pediatric otorhinolaryngology · 2026
Non-usage rates after paediatric cochlear implantation: A systematic review and meta-analysis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Au Joy Xin Yi, Tan Benjamin Kye Jyn, Mandal Swarnadeep, James Juanita Jaslin, Choo Li Xuan, Gao Esther Yanxin, Teo Yao Hao, Goh Xueying, Loh Woei Shyang
Аннотация
OBJECTIVE: To determine the prevalence of long-term cochlear implant (CI) non-use and partial use in paediatric recipients and identify factors associated with suboptimal adherence.
DATA SOURCES: A systematic search of major electronic databases including PubMed, Embase, and the Cochrane Library was performed to identify studies reporting CI usage patterns in paediatric populations.
REVIEW METHODS: We conducted a systematic review and meta-analysis of 29 studies (n = 2595) following PRISMA guidelines. Pooled prevalence estimates were calculated using random-effects models with generalized linear mixed model.
RESULTS: The pooled prevalence of non-use was 4.45% (95% CI: 2.21-8.78, p < 0.0001) and partial use (<8 h/day) was 8.99% (95% CI: 5.91-13.44, p < 0.0001). Non-use was highest in Oceania at 27.27% (95% CI = 9.05-58.57), and lowest in Europe at 1.99% (95% CI: 1.00-3.94). Compared to normal population, non-use rates are also significantly higher among specific clinical subgroups (16.29% vs 2.29%). Longer duration of hearing loss was associated with a higher prevalence of partial-use (coefficient 0.477, p < 0.001). Compared to 12-24 months, early implantation (=<12 months) was associated with reduced partial use (6.89% vs 16.81%). No significant associations were found with follow up duration, sex or implant laterality.
CONCLUSION: More than one-tenth of recipients demonstrated suboptimal long-term adherence, varying by region, clinical subgroups, hearing loss duration, and implantation age. Targeted, risk-stratified strategies are needed to improve adherence and long-term outcomes.
DATA SOURCES: A systematic search of major electronic databases including PubMed, Embase, and the Cochrane Library was performed to identify studies reporting CI usage patterns in paediatric populations.
REVIEW METHODS: We conducted a systematic review and meta-analysis of 29 studies (n = 2595) following PRISMA guidelines. Pooled prevalence estimates were calculated using random-effects models with generalized linear mixed model.
RESULTS: The pooled prevalence of non-use was 4.45% (95% CI: 2.21-8.78, p < 0.0001) and partial use (<8 h/day) was 8.99% (95% CI: 5.91-13.44, p < 0.0001). Non-use was highest in Oceania at 27.27% (95% CI = 9.05-58.57), and lowest in Europe at 1.99% (95% CI: 1.00-3.94). Compared to normal population, non-use rates are also significantly higher among specific clinical subgroups (16.29% vs 2.29%). Longer duration of hearing loss was associated with a higher prevalence of partial-use (coefficient 0.477, p < 0.001). Compared to 12-24 months, early implantation (=<12 months) was associated with reduced partial use (6.89% vs 16.81%). No significant associations were found with follow up duration, sex or implant laterality.
CONCLUSION: More than one-tenth of recipients demonstrated suboptimal long-term adherence, varying by region, clinical subgroups, hearing loss duration, and implantation age. Targeted, risk-stratified strategies are needed to improve adherence and long-term outcomes.